Abstract:Objective To investigate the effects of PlK-1 gene on the chemotherapeutic sensitivity of pancreatic carcinoma cell line AsPC-1 response to gemcitabine. Methods ①AsPC-1 cells transfected with Plk-1 overexpression plasmid(pcDNA/ Plk-1) was selected as treatment group,and empty vector(pcDNA3.1) was selected as control group,total RNA and total protein were extracted,AsPC-1 cells without any treatment was selected as blank group. The RT-PCR and western blotting assay were performed to detect the expression of Plk-1 gene and protein level in AsPC-1 cells after transfection with pcDNA/Plk-1 for 24 hours. ②Flow cytometry assay was used to detect the cell apoptosis change after treatment. ③MTT assays were used to test the effect of different concentration of gemcitabine on proliferation of transfected AsPC-1 cells. Results ①The expression level of Plk-1 mRNA in non-transfection AsPC-1 group,empty vector pcDNA3.1 transfection group and pcDNA3.1/Plk-1 transfection group were(2.14±0.16),(2.18±0.15),(2.58±0.18); the Plk-1 mRNA in pcDNA3.1/Plk-1 transfection group was higher than that in other groups,the differences were statistically significant(P < 0.01). According to Western blot results,the protein expression level of Plk-1 in non-transfection AsPC-1 group,empty vector pcDNA3.1 transfection group and pcDNA3.1/Plk-1 transfection group were(0.989±0.018),(1.022±0.021),(1.243±0.143),the protein expression level of Plk-1 in pcDNA3.1/Plk-1 transfection group was higher than that in other groups,the differences were statistically significant(P < 0.01). ②Under the function of Gemcitabine,apoptosis rate in pcDNA3.1/Plk-1 transfection group was lower than that in nontransfection group and empty vector transfection group,the differences were statistically significant(P < 0.01). ③The inhibition proliferation rate of AsPC-1 cells of pcDNA3.1/ Plk-1 transfection group was higher than that of non-transfection group and empty vector transfection group,the differences was statistically significant(P < 0.01). Conclusion Overexpression of Plk-1 gene in AsPC-1 cells can significantly decrease gemcitabine induced apoptosis and increase its chemotherapeutic resistentivity.

Apoptosis Induction with Polo-Like Kinase-1 Antisense Phosph-Orothioate Oligodeoxynucleotide of Colon Cancer Cell Line SW480

Effect of K‐ras Antisense Oligodeoxynucleotides on Human Pancreatic Cancer Cell Line PaTu 8988S

Inhibitory Effect of Platycodin D on Human Colonic Cancer SW620 Cell Proliferation

[Knockdown of PLK1 Mrna by Special Sirna].

Efficient inhibition of human colorectal carcinoma growth by RNA interference targeting polo-like kinase 1 in vitro and in vivo.

Overexpression of PlK-1 gene effects of PlK-1 gene on the chemotherapeutic sensitivity of pancreatic carcinoma cell line AsPC-1 response to gemcitabine

Effects of RNA Interference Polo-Like Kinase-1 Gene on Telomerase Activity of Human Colon Cancer Cell

Enhanced Chemosensitivity to CPT-11 in Colorectal Carcinoma Xenografts by Small Hairpin RNA Interference Targeting PLK1.

Inhibition of Plk-1 gene expression enhences 5-Fu and CDDP induced apoptosis of gastric cancer cells

RNA Interference Targeting PLK1 Induced Human Prostatic Carcinoma Cell Line PC-3 Apoptosis

Inhibition of Phospholipased2 Increases Hypoxia-Induced Human Colon Cancer Cell Apoptosis Through Inactivating of the PI3K/AKT Signaling Pathway

Depletion of Pi3k P85 Alpha Induces Cell Cycle Arrest and Apoptosis in Colorectal Cancer Cells

Inhibition of Polo-like kinase 1 (PLK1) triggers cell apoptosis via ROS-caused mitochondrial dysfunction in colorectal carcinoma

Influence of antisense oligodeoxynucleotide targeting chk2 on apoptosis of SKOV-3 cells of ovarian cancer induced by DDP

Effect of Antisense Oligodeoxynucleotide of Telomerase RNA on Telomerase Activity and Cell Apoptosis in Human Colon Cancer

Proteasome activation is critical for cell death induced by inhibitors of polo-like kinase 1 (PLK1) in multiple cancers

Plk1 As A Potential Drug Target in Cancer Therapy

PC-407 Inhibited Proliferation and Induced Apoptosis in Human Colon Cancer SW-1116 Cells

Targeted Inhibition of Polo‐like Kinase 1 by a Novel Small‐molecule Inhibitor Induces Mitotic Catastrophe and Apoptosis in Human Bladder Cancer Cells

Effects of c-FLIP antisense oligodeoxynucleotides on growth and apoptosis of lung cancer cell line A549

Cytotoxic Mechanism of PLK1 Inhibitor GSK461364 Against Osteosarcoma: Mitotic Arrest, Apoptosis, Cellular Senescence, and Synergistic Effect with Paclitaxel.